Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06681610
What this trial is testing

Testing Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Parc de Salut Mar 50
Testing effectiveness (Phase 2)Study completedNCT05808764
What this trial is testing

Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 11
Not applicableLooking for participantsNCT07257302
What this trial is testing

Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
National Center of Neurology and Psychiatry, Japan 25
Not applicableLooking for participantsNCT06578195
What this trial is testing

ASSESS ALL ALS Study

Who this might be right for
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix 2,000
Not applicableLooking for participantsNCT05137665
What this trial is testing

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Who this might be right for
Amyotrophic Lateral SclerosisMovement DisordersDegenerative Disorder+1 more
Target ALS Foundation, Inc. 1,000
Testing effectiveness (Phase 2)Study completedNCT04788745
What this trial is testing

Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
The University of Queensland 21
Not applicableLooking for participantsNCT07286565
What this trial is testing

Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening

Who this might be right for
Spinal Muscular Atrophy (SMA)Duchenne Muscular Dystrophy (DMD)
Centre Hospitalier Universitaire de Liege 100
Early research (Phase 1)UnknownNCT03296501
What this trial is testing

Intraspinal Transplantation of Autologous ADRC in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Mossakowski Medical Research Centre Polish Academy of Sciences 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07174492
What this trial is testing

Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
AB Science 412
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513546
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients

Who this might be right for
Amyotrophic Lateral SclerosisALS
PLL TX AUSTRALIA PTY LTD 153
Not applicableStudy completedNCT01522079
What this trial is testing

Spinal Muscular Atrophy and Cardiac Autonomic Function

Who this might be right for
Spinal Muscular Atrophy
Centro Universitário Augusto Motta 9
Not applicableStudy completedNCT00606918
What this trial is testing

Validation of a New Device to Measure Neuromuscular Disease Progression

Who this might be right for
Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders
Massachusetts General Hospital 120
Very early researchActive Not RecruitingNCT06454682
What this trial is testing

An IIT Clinical Study to Evaluate the Safety and Efficacy of a Single Intrathecal Injection of RJK002 in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
RJK Biopharma Ltd 9
Testing effectiveness (Phase 2)Looking for participantsNCT05824169
What this trial is testing

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

Who this might be right for
Spinal Muscular Atrophy
GeneCradle Inc 18
Not applicableUnknownNCT05272969
What this trial is testing

Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease

Who this might be right for
Pompe Disease (Late-onset)Inclusion Body MyositisSpinal Muscular Atrophy Type 3+1 more
LMU Klinikum 95
Early research (Phase 1)UnknownNCT03049046
What this trial is testing

CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Chemigen, LLC 21
Early research (Phase 1)Study completedNCT02655614
What this trial is testing

GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Genentech, Inc. 54
Testing effectiveness (Phase 2)UnknownNCT04950647
What this trial is testing

Efficacy and Safety of Nitrazine in the Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 150
Not applicableStudy completedNCT04947436
What this trial is testing

ALS and Airway Clearance (ALSAC) Therapy

Who this might be right for
Amyotrophic Lateral SclerosisRespiratory Muscle Weakness
The University of Texas Health Science Center at San Antonio 28
Not applicableStudy completedNCT03489200
What this trial is testing

EH301 for the Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Elysium Health 32
Next Page